Novobiocin
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration | intravenous | 
| ATCvet code | |
| Pharmacokinetic data | |
| Bioavailability | negligible oral bioavailability | 
| Metabolism | excreted unchanged | 
| Elimination half-life | 6 hours | 
| Excretion | renal | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.005.589 | 
| Chemical and physical data | |
| Formula | C31H36N2O11 | 
| Molar mass | 612.632 g·mol−1 | 
| 3D model (JSmol) | |
| Melting point | 152 to 156 °C (306 to 313 °F) (dec.) | 
| 
 | |
| 
 | |
| (verify) | |
Novobiocin, also known as albamycin, is an aminocoumarin antibiotic that is produced by the actinomycete Streptomyces niveus, which has recently been identified as a subjective synonym for S. spheroides a member of the class Actinomycetia. Other aminocoumarin antibiotics include clorobiocin and coumermycin A1. Novobiocin was first reported in the mid-1950s (then called streptonivicin).